Arkolith/Insider Trading/BIOA/Form 4/A

Hemrajani Rekha

DirectorBioAge Labs, Inc. (BIOA) · full profile →Form 4/A · filed Mar 10, 2025
Net Buying
Open-Market Buys
$54K
Open-Market Sells
$0
Net Open-Market Flow
$54K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 27, 2024Buy(P)3K$18.00$54K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001415889-25-007506) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML